The need and ongoing efforts to understand the full value of improved influenza vaccines.

Bresee, Joseph; Koh, Mitsuki; Chadwick, Christopher; Jit, Mark; Soble, Adam; Lambach, Philipp

Bresee, Joseph; Koh, Mitsuki; Chadwick, Christopher; Jit, Mark; Soble, Adam; Lambach, Philipp.

Afiliação

Bresee J; Task Force for Global Health, Decatur, GA, USA. Electronic address: jbresee@taskforce.org.
Koh M; Immunization, Vaccines and Biologicals Department, World Health Organization, Geneva, Switzerland.
Chadwick C; Epidemic and Pandemic Preparedness and Prevention Department, World Health Organization, Geneva, Switzerland.
Jit M; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Tropical Hygiene and Medicine, London, UK.
Soble A; MMGH Consulting GmbH, Zurich, Switzerland.
Lambach P; Immunization, Vaccines and Biologicals Department, World Health Organization, Geneva, Switzerland.

Vaccine ; 41(48): 7044-7046, 2023 11 22.

Article em En | MEDLINE | ID: mdl-37872012

Assuntos

Vacinas contra Influenza; Influenza Humana; Infecções por Orthomyxoviridae; Humanos; Influenza Humana/prevenção & controle; Infecções por Orthomyxoviridae/prevenção & controle; Estudos Longitudinais

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Infecções por Orthomyxoviridae / Influenza Humana Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google